MSNews updates are on hold until further notice. Sign-up on our mailing list here to be notified when we are back.
Big MS THC Trial Fully Enrolled
Submitted by art on Mon, 2008-08-04 11:06.
The CUPID (Cannabinoid Use in Progressive Inflammatory brain Disease) study at the Peninsula Medical School in Plymouth has reached an important milestone with the news that the full cohort of 493 people with multiple sclerosis (MS) has been recruited to the study.
CUPID is a clinical trial which will evaluate whether tetrahydrocannabinol (THC), one of many compounds found in the in the cannabis plant (and the main active ingredient) is able to slow the progression of MS.